Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Conrozier, Thierry
• dc.contributor.author Raman, Raghu
• dc.contributor.author Chevalier, Xavier
• dc.contributor.author Henrotin, Yves
• dc.contributor.author Monfort Faure, Jorge
• dc.contributor.author Diraçoglù, Demirhan
• dc.contributor.author Bard, Hervé
• dc.contributor.author Baron, Dominique
• dc.contributor.author Jerosch, Jörg
• dc.contributor.author Richette, Pascal
• dc.contributor.author Migliore, Alberto
• dc.date.accessioned 2022-06-29T06:10:36Z
• dc.date.available 2022-06-29T06:10:36Z
• dc.date.issued 2021
• dc.description.abstract Viscosupplementation (VS) is a symptomatic treatment for knee and other joint osteoarthritis (OA). Despite a long history of use, conflicting opinions remain on the best clinical indications and the most appropriate patients to be treated with intra-articular hyaluronic acid (IA-HA), the optimal dosing regimen and the modalities of retreatment. A multidisciplinary committee of European experts on OA (EUROVISCO) was constituted to formulate recommendations, aimed at helping physicians in the decision-making and the optimal achievement of VS. Before each session members were tasked to collate an exhaustive literature review. Level of evidence and strength of recommendation were based on the level of agreement for each item according to the Delphi method. In 2015, a consensus position was proposed for 24 statements. Among those that obtained a consensual agreement, the working group stressed that VS is effective in mild/moderate knee OA but is not an alternative to surgery in advanced OA, and that dosing regimen must be supported by controlled trials. In 2018, two decision algorithms for the retreatment with IA-HA in knee OA were published. Among the key recommendations, the experts recommended to re-treat every year patients with high risk of OA progression, even if not symptomatic. In 2020, EUROVISCO published two sets of recommendations for the design of clinical trials on the disease-modifying effect of VS and for optimizing the results of VS. The working group underlined that an accurate analysis of radiological features and symptoms and a careful clinical examination may improve the chances of success of VS, as well as good technique of injection and the use of imaging guidance. Based on the exhaustive analysis of the literature and their own clinical experience, the EUROVISCO experts offer a wide range of recommendations intended to help practitioners, particularly in certain cases where the specific characteristics of the patients make the therapeutic decision difficult.
• dc.format.mimetype application/pdf
• dc.identifier.citation Conrozier T, Raman R, Chevalier X, Henrotin Y, Monfort J, Diraçoglù D, Bard H, Baron D, Jerosch J, Richette P, Migliore A. Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group. Ther Adv Musculoskelet Dis. 2021 May 28;13. DOI: 10.1177/1759720X211018605
• dc.identifier.doi http://dx.doi.org/10.1177/1759720X211018605
• dc.identifier.issn 1759-720X
• dc.identifier.uri http://hdl.handle.net/10230/53631
• dc.language.iso eng
• dc.publisher SAGE Publications
• dc.relation.ispartof Ther Adv Musculoskelet Dis. 2021 May 28;13:1759720X211018605
• dc.rights © The Author(s), 2021. Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/
• dc.subject.keyword EUROVISCO
• dc.subject.keyword Hip
• dc.subject.keyword Hyaluronic acid
• dc.subject.keyword Intra-articular injection
• dc.subject.keyword Knee
• dc.subject.keyword Osteoarthritis
• dc.subject.keyword Recommendations
• dc.subject.keyword Viscosupplementation
• dc.title Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion